J&J Ortho Evra Patch New Warning May Prompt Changes To Lauded TV Ad
Johnson & Johnson may have to modify its novel direct-to-consumer TV commercial for Ortho Evra because of the addition of a bolded warning to labeling for the contraceptive patch
You may also be interested in...
FDA Acting Commissioner Lester Crawford is highlighting the benefits of direct-to-consumer advertising rather than the need for agency regulation of the practice
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials